Why children with inflammatory bowel disease are diagnosed at a younger age than their affected parent

J C Lee1, S Bridger, C McGregor

  • 1St Mark's Hospital, Northwick Park, Harrow, Middlesex, UK.

Gut
|May 14, 1999
PubMed

Insights

Genetic anticipation in inflammatory bowel disease (IBD) is not supported. Observed age differences in Crohn's disease and ulcerative colitis diagnoses between parents and children are due to ascertainment bias, not genetic factors.

Area of Science:

  • Genetics
  • Gastroenterology
  • Pediatrics

Background:

  • Genetic anticipation is a proposed mechanism for earlier disease onset in successive generations.
  • Observed age differences in Crohn's disease diagnosis between parents and offspring have fueled this hypothesis.
  • Investigating familial inflammatory bowel disease (IBD) patterns is crucial for understanding disease inheritance.

Purpose of the Study:

  • To compare parent-child pairs with Crohn's disease and ulcerative colitis against sporadic IBD cases.
  • To quantify the potential role of ascertainment bias in observed age differences at diagnosis.
  • To investigate genetic anticipation and genomic imprinting in IBD families.

Main Methods:

  • Studied 137 affected parent-child pairs from 96 families and 214 sporadic inflammatory bowel disease (IBD) patients.
  • Ascertained age at onset and diagnosis through interviews, with disease confirmation from clinical records.
  • Analyzed age differences in Crohn's disease, ulcerative colitis, and mixed disease families.

Main Results:

  • No evidence of genetic anticipation or genomic imprinting was found in the studied IBD families.
  • Observed age differences at diagnosis between parents and children were consistent with ascertainment bias.
  • Parental sex did not influence offspring's age at diagnosis or disease extent.

Conclusions:

  • Ascertainment bias, not genetic anticipation, explains age differences in IBD diagnoses between parents and children.
  • The study refutes genetic anticipation as a factor in the observed familial age at diagnosis for IBD.
  • Findings highlight the importance of considering study design biases in genetic research.
Abstract

Related Concept Videos

Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...